COMMERCIALIZATION TRANSITION AGREEMENTCommercialization Transition Agreement • May 2nd, 2006 • Cerus Corp • Biological products, (no disgnostic substances)
This COMMERCIALIZATION TRANSITION AGREEMENT (“Agreement”) is entered into on February 12, 2006 (the “Execution Date”) and is effective as of February 1, 2006 (the “Effective Date”) by and among Baxter Healthcare S.A., a corporation organized under the laws of Switzerland (“BHSA”), Baxter Healthcare Corporation, a company organized under the laws of Delaware (“BHC”), and Cerus Corporation, a company organized under the laws of Delaware (“Cerus”). BHSA and BHC are sometimes collectively referred herein to as “Baxter.” The foregoing entities are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
